Safety Profile of Schedule III Buprenorphine and Schedule II Oral Opioids in Elderly with Chronic Low Back Pain: A Retrospective US Medicare Claims Analysis
Objective: This study aimed to evaluate and compare the safety of CIII buprenorphine and oral CII opioids among Medicare patients with chronic Low-Back Pain (cLBP). Methods: The retrospective study was conducted in Merative Medicare MarketScan® database (2018-2021). The first date of CIII buprenorphine or oral CII opioid medication prescription was defined...Read More